European Approval of New Sleeping Sickness Drug Marks Progress—and Raises Tough Questions

The recent endorsement by European regulators of acoziborole, a new once-only pill to treat sleeping sickness, represents a notable scientific breakthrough—but is it the silver bullet publicized by global health advocates? While the approval by the European Medicines Agency sets the stage for wider availability in Congo and neighboring countries, it also exposes enduring gaps in disease control strategies that demand urgent attention from policymakers focused on protecting American interests abroad. Is This Truly the End of a Neglected Disease—or Just Another Temporary Fix? Sleeping sickness, or human African trypanosomiasis, primarily afflicts some of Africa’s most impoverished and unstable regions—areas...